Nature Communications, 2015 · DOI: 10.1038/ncomms9466 · Published: October 27, 2015
This study investigates whether montelukast, an anti-asthmatic drug, can improve cognitive function in aged rats. The researchers found that montelukast reduces neuroinflammation, elevates hippocampal neurogenesis, and improves learning and memory in old animals. The effect is mediated through inhibition of the GPR17 receptor, suggesting a potential target for treating dementias.
Inhibition of leukotriene receptor signaling might represent a safe and druggable target to restore cognitive functions in old individuals and pave the way for future clinical translation for the treatment of dementias.
Montelukast reduces age-associated neuroinflammation, particularly microglia activation, suggesting a less reactive phenotype in the brain.
Montelukast promotes hippocampal neurogenesis, which is crucial for learning and memory, especially in situations where neurogenesis is compromised due to aging.